Paragon Biosciences is composed of a number of companies that are committed to creating revolutionary medicines and medical treatments. These companies have successfully obtained 13 FDA approvals over the past decade. The Paragon management keeps a careful eye on the needs of patients. When they notice a great need for a specific kind of drug, they will start a company to create it. And they recognize that there is more than enough of this for them. There are currently over 6,000 diseases that have yet to have an effective treatment available.
Paragon has been led by chairman and CEO Jeff Aronin since 2010. During that time, he has also served as non-executive chairman Paragon portfolio companies Castle Creek Pharmaceuticals and Harmony Biosciences. He had already had several years of leadership in medical innovation prior to joining the Paragon team. Jeff Aronin was born December 8, 1967 (http://www.worldbusinesschicago.com/profile/jeff-aronin/). In 2000 he founded Ovation Pharmaceuticals Inc., which he led as its CEO until 2009. During his many years in the business, he has garnered much experience in strategic and business development, finance, and brand marketing.
He is also a recognized expert in complex science complex science, rare diseases, and drug development. Aronin is highly respected for having a special talent of getting professionals to work well together. Jeff Aronin has been highly awarded and honored throughout the years for his extensive work. Some of the most prestigious: He won the 2017 Weizmann Leadership Award from the Brain Research Foundation; in 2010 he won the Illinois Holocaust Museum & Education Center Humanitarian Award; in 2007 Jeff won the Epilepsy Foundation of Greater Chicago Rowner Award.
Experts say that it is very likely that he will continue to garner more honors and awards in the future. He and his wife, Lisa, are happily married. The couple has three daughters.